Definitive Contract ING15PC00044
Award Date 7/27/15
Potential Completion Date 11/24/15
Potential Value $285K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $127,989.57 firm fixed-price delivery order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing technologies. The contract has a period of performance ending on July 30, 2026. Illumina, a for-profit manufacturer, has been awarded multiple federal contracts and blanket purchase agreements to provide a range of genomic sequencing platforms,...
- This firm fixed price federal contract was awarded by the Department of the Interior U.S. Geological Survey Office of Acquisitions and Grants to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $362,870.60 contract is for the provision of DNA sequencing equipment and consumable supplies. Illumina has previously provided similar sequencing systems and reagents to support research and diagnostics programs across various federal agencies, including the National...
- This is a firm fixed-price delivery order awarded by the National Institute of Environmental Health Sciences, a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $78,703.47 contract is not associated with a set-aside. Illumina has previously received prime and subcontract awards from federal agencies such as the NIH, CDC, USDA, and VA to provide sequencing instruments, consumables, and bioinformatics support for genomic research and diagnostic...
- This is a firm fixed-price purchase order awarded by a civilian federal agency to Illumina, Inc., a for-profit manufacturer of genetic sequencing technologies. The $47,945.52 contract is for kitted reagents to prepare DNA sequencing libraries and complete four instrument runs using Illumina's HiSeq2000 DNA sequencer, generating 200 base pairs of sequence data per molecule. The award is not associated with a set-aside designation or a larger federal contract vehicle. Illumina has been awarded...
- This is a firm fixed price delivery order awarded to Illumina, Inc. by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The $149,950.32 contract is for the provision of Illumina's genomic sequencing systems, reagents, and related services to support research and diagnostic applications. Illumina has a history of providing sequencing products and services to federal agencies including the NIH, CDC, USDA, and VA. The award is not...
- This is a firm fixed price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and consumables. The $164,956.64 contract was awarded on September 15, 2015 with a period of performance ending on January 6, 2016. The contract does not have a set-aside designation. Illumina has previously been awarded prime federal...
- This is a $19,812.90 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract has an ultimate completion date of August 3, 2026 and was awarded on August 4, 2025. No set-aside designation was used. Illumina, a leading provider of DNA and RNA sequencing technologies, will deliver a range...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The $122,145.01 firm fixed price delivery order contract was awarded on September 15, 2017 with a completion date of December 15, 2017. It did not have a set-aside designation. Illumina has previously provided a range of genomic sequencing...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $21,323.61 contract is for the provision of various Illumina sequencing systems, reagents, and related maintenance services to support genomic research and analysis across federal agencies. Illumina has a history of prime federal contract awards...